Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alembic Pharmaceuticals receives US FDA product approvals (Final & Tentative) during the quarter ended 30th June, 2024.
03-07-2024

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alembic Pharmaceuticals Limited has received USFDA Tentative Approval for Bosutinib Tablets 100mg and 500 mg.
01-07-2024

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alembic Pharmaceuticals receives USFDA Final Approval for Doxycycline Capsules 40mg.
28-06-2024

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Please find attached herewith the Intimation received from our RTA.
26-06-2024

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Closure of Trading Window

Please find attached the Intimation of Closure of Trading Window
26-06-2024

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find attached herewith the Newspaper Publication.
24-06-2024

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Of Record Date For Dividend Payment

Intimation of Record Date for Payment of Dividend.
21-06-2024

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Business Responsibility and Sustainability Reporting (BRSR)

Please find attached herewith the BRSR of the Company for the Financial Year 2023-24.
21-06-2024

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Reg. 34 (1) Annual Report.

Please find attached herewith the 14th Annual Report of the Company.
21-06-2024

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Notice Of 14Th AGM To Be Held On Monday, 22Nd July, 2024.

Please find attached herewith the Notice of the 14th AGM of the Company to be held on Monday, 22nd July, 2024.
21-06-2024